hepatitis D HDV
Selected indexed studies
- Hepatitis D: A Review. (JAMA, 2023) [PMID:37943548]
- Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials. (Expert Opin Investig Drugs, 2022) [PMID:34482769]
- The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. (J Hepatol, 2020) [PMID:32335166]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Hepatitis D: A Review. (2023) pubmed
- Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials. (2022) pubmed
- The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. (2020) pubmed
- Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. (2021) pubmed
- Hepatitis D (DELTA). (2022) pubmed
- Hepatitis D. (2005) pubmed
- EASL Clinical Practice Guidelines on hepatitis delta virus. (2023) pubmed
- Hepatitis D revival. (2011) pubmed
- Hepatitis D: advances and challenges. (2022) pubmed
- Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis. (2021) pubmed